Innovating Works

CTX

Desconocido
ATECT: Advanced T cell Engineered for Cancer Therapy CELLECTICS THERAPEUTICS SAS participó en un FP7: "T-cell engineering strategies for Cancer therapy, either Chimeric Antigen Receptors (CARs) or TCR transfer holds promise to revolutionize c...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.